NAUT News and Press, Nautilus Biotechnology Inc. From 03/29/23

2023-03-29 17:30:23 ET Gainers: Erasca ( ERAS ) +8% . KalVista Pharmaceuticals ( KALV ) +5% . Ramaco Resources ( METC ) +5% . Pyxis Oncology ( PYXS ) +5% . Yellow Corporation ( YELL ) +5% . Losers: Semtech  ( SMTC ...

SEATTLE, March 23, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the upcoming B. Riley Securities’ Disruptive Biotech ...

2023-03-17 14:17:17 ET Whether you’re trading high-priced or penny stocks, there’s no denying that March has been incredibly volatile. If you know how to trade low-priced stocks, this environment has likely been very opportunistic. That’s because penny stocks ȁ...

2023-03-10 07:34:37 ET The following slide deck was published by Nautilus Biotechnology, Inc. in conjunction with this event. For further details see: Nautilus Biotechnology (NAUT) Investor Presentation - Slideshow

SEATTLE, March 07, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, announced the selection of three research proposals submitted to the First Access Ch...

Nautilus Biotechnology, Inc. (NAUT) Q4 2022 Earnings Conference Call February 23, 2023 8:30 AM ET Company Participants Sujal Patel - Co-Founder and CEO Anna Mowry - CFO Parag Mallick - Co-Founder and Chief Scientist Conference Call Participants Max Masucci ...

SEATTLE, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the upcoming 43 rd Annual Cowen Health Care Conference. ...

SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the fourth quarter and full year of 2022 before market open o...

SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the opening of its new office space at University Town Center in San ...

SEATTLE, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, and the Translational Genomics Research Institute (TGen), part of City of Hope, today announced a partnership to e...